Sandbox 111: Difference between revisions
No edit summary |
No edit summary |
||
Line 16: | Line 16: | ||
'''Drug Binding Site''' | '''Drug Binding Site''' | ||
'''Additional Features''' | |||
<scene name='Sandbox_111/His37/1'>His37</scene> – His37 has been found to exhibit significant proton selectivity. This suggests that His37 is involved in the opening of the conductive channel. The channel is non-conductive when His37 is not protonated, and conductive when it is in the protonated state (Pielak/Chou). | |||
<scene name='Sandbox_111/Trp41_ring/1'>Trp41</scene> – Replacing Trp41 with a substitute amino acid results in increased channel current in in both directions. As such, the Trp 41 site is important to directional selectivity, in that it regulates the direction of the proton channel flow. This is accomplished in part because it forms a ring that prevents water from entering the channel and reaching the His37, and thus protonating if the pH is high, from the C-terminus(Pielak/Chou). | |||
In addition, the proton transport channel is used to equalize the pH in the channel with that of the cytoplasm in the host cell. This prevents rearrangement of the haemmagglutanin during its transport to the host cell. (Schnell) | |||
'''Credits''' | '''Credits''' | ||
Line 45: | Line 51: | ||
Stephenson I, Nicholson KG. Influenza: vaccination and treatment. Eur Respir J 2001; 17: 1282-93. | Stephenson I, Nicholson KG. Influenza: vaccination and treatment. Eur Respir J 2001; 17: 1282-93. | ||
Pielak RM, Chou JJ. "Infuenza M2 proton channels". BBAMEM-80262; No. of pages: 8; 4C: 2, 3, 5, 6. |